Phospholipidosis in healthy subjects participating in clinical studies: Ultrastructural findings in white blood cells

Experimental and Toxicologic Pathology

Volumn 62, Issue 5, 2010, Pages 567-571

  Pospischil, Andreas ^a   Walther, Paul ^b   Dingemanse, Jasper ^c  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY OF ULM   (Germany)

^c ACTELION PHARMACEUTICALS LTD   (Switzerland)

Author keywords

Drug induced; Electron microscopy; Healthy volunteers; Monocytes; Neutrophilic granulocytes; Phospholipdiosis; Phospholipid like structures

Indexed keywords

ANTIHYPERTENSIVE AGENT; ENALAPRIL; PLACEBO;

ADULT; ARTICLE; CELL ULTRASTRUCTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG SAFETY; DRUG TOLERABILITY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; LEUKOCYTE; LIPIDOSIS; MALE; MORNING DOSAGE; MULTIPLE DRUG DOSE; NORMAL HUMAN; PHARMACODYNAMICS; PHASE 1 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL;

EID: 77955512961     PISSN: 09402993     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.etp.2009.07.007     Document Type: Article

References (23)

1. Anderson N., Borlak J. Minireview. Drug induced phospholipidosis. FEBS Lett 2006, 580:5333-5540.
2. Letter to the editor. Toxicol Pathol 2007, 35:325.
3. Blanchette-Mackie E.J. Intracellular cholesterol trafficking: role of the NPC1 protein. Biochim Biophys Acta 2000, 1486:171-183.
4. Dake M.D., Madison J.M., Montgomery C.K., Shellito J.E., Hinchcliffe W.A., Winkler M.L., et al. Electron microscopic demonstration of lysosomal inclusion bodies in lung, liver, lymph nodes, and blood leukocytes of patients with amiodarone pulmonary toxicity. Am J Med 1985, 78:506-512.
5. Drenckhahn D., Kleine L., Lüllmann-Rauch R. Lysosomal alterations in cultured macrophages exposed to anorexigenic and psychotropic drugs. Lab Invest 1976, 35:116-123.
6. Halliwell W.H. Cationic amphiphilic drug-induced phospholipidosis. Toxicol Pathol 1997, 25:53-60.
7. Harzer K., Massenkeil G., Frohlich E. Concurrent increase of cholesterol, sphingomyelin and glucosylceramide in the spleen from nonneurologic Niemann-Pick type C patients but also patients possibly affected with other lipid trafficking disorders. FEBS Lett 2003, 537:177-181.
8. Hostetler K.Y., Matsuzawa Y. Studies on the mechanism of drug-induced lipidosis. Cationic amphiphilic drug inhibition of lysosomal phospholipases A and C. Biochem Pharmacol 1981, 30:1121-1126.
9. Hruban Z. Pulmonary changes induced by amphiphilic drugs. Environ Health Perspect 1976, 16:111-118.
10. Joshi U.M., Kodavanti P.R., Coudert B., Dwyer T.M., Mehendale H.M. Types of interaction of amphiphilic drugs with phospholipid vesicles. J Pharmacol Exp Ther 1988, 246:150-157.
11. Lüllmann H., Lüllmann-Rauch R., Wassermann O. Drug-induced phospholipidoses. II. Tissue distribution of the amphiphilic drug chlorphentermine. CRC Crit Rev Toxicol 1975, 4:185-218.
12. Lüllmann H., Lüllmann-Rauch R., Wassermann O. Lipidosis induced by amphiphilic cationic drugs. Biochem Pharmacol 1978, 27:1103-1108.
13. Lüllmann-Rauch R. Drug-induced lysosomal storage disorders. Lysosomes in biology and pathology 1979, vol. 6:49-130. North-Holland, Amsterdam, The Netherlands.
14. McGookey D.J., Anderson R.G. Morphological characterization of the cholesteryl ester cycle in cultured mouse macrophage foam cells. J Cell Biol 1983, 97:1156-1168.
15. Reasor M.J. A review of the biology and toxicologic implications of the induction of lysosomal lamellar bodies by drugs. Toxicol Appl Pharmacol 1989, 97:47-56.
16. Reasor M.J., Kacew S. Drug-induced phospholipidosis: functional consequences?. Exp Biol Med 2001, 226:825-830.
17. Robenek H., Schmitz G. Ca11 antagonists and ACAT inhibitors promote cholesterol efflux from macrophages by different mechanisms. II. Characterization of intracellular morphologic changes. Arteriosclerosis 1988, 8:57-67.
18. Sawada H., Kenji T., Asahi S. A toxicogenomic approach to drug-induced phospholipidosis: analysis of its induction mechanism and establishment of a novel in vitro screening system. Toxicol Sci 2005, 83:282-292.
19. Schmitz G., Müller G. Structure and function of lamellar bodies, lipid-protein complexes involved in storage and secretion of cellular lipids. J Lipid Res 1991, 32:1539-1570.
20. Schmitz G., Grandl M. Lipid homeostasis in macrophages - implications for atherosclerosis. Rev Physiol Biochem Pharmacol 2008, 160:93-125.
21. Vanier M.T. Biochemical studies in Niemann-Pick disease. I. Major sphingolipids of liver and spleen. Biochim Biophys Acta 1983, 750:178-184.
22. Xia Z., Ying G., Hansson A.L., Karlsson H., Xie Y., Bergstrand A., et al. Antidepressant-induced lipidosis with special reference to tricyclic compounds. Prog Neurobiol 2000, 60:501-512.
23. Zhu Y., Traub L.M., Kornfeld S. High-affinity binding of the AP-1 adaptor complex to trans-Golgi network membranes devoid of mannose 6-phosphate receptors. Mol Biol Cell 1999, 10:537-549.